{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-199061","form_type":"8-K","ticker":"FLGT","cik":"0001674930","company_name":"Fulgent Genetics, Inc.","filed_at":"2026-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.714077+00:00","generated_at":"2026-05-15T00:20:12.030913+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Fulgent Q1 2026: GAAP EPS -$0.80, revenue $71.1M, reiterates FY2026 guidance","bullets":["GAAP net loss of $24.8M ($0.80/share); non-GAAP loss of $11.0M ($0.36/share).","Revenue $71.1M; GAAP gross margin 30.2%, non-GAAP gross margin 32.3%.","Adjusted EBITDA loss of $15.2M in Q1 2026.","Cash, equivalents, restricted cash & marketable securities $604.7M; expects ~$106M tax refund.","Bought back ~2.6M shares for $40.1M in Q1; FY2026 revenue guidance reaffirmed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-199061","json":"https://secwatch.observer/filing/0001193125-26-199061.json","markdown":"https://secwatch.observer/filing/0001193125-26-199061.md","text":"https://secwatch.observer/filing/0001193125-26-199061.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1674930/000119312526199061/0001193125-26-199061-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1674930/000119312526199061/flgt-20260501.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T00:20:12.030913+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"65666183ab5ab97e2c880366eff67b382e818ebe","claim":"Fulgent Genetics, Inc. reported first quarter ended March 31, 2026 results: revenue 71.1 million, net income -24.8 million, EPS -0.80. Guidance reaffirmed.","evidence_excerpt":"for fiscal year 2026 • Executed on stock repurchase program; purchased approximately 2.6 million shares in the first quarter of 2026 using $40.1 million in cash • Revenue of $71.1 million • GAAP gross profit of $21.5 million, or GAAP gross margin of 30.2%; Non-GAAP gross profit of $23.0 million, or Non-GAAP gross margin of 32.3% • GAAP loss of $24.8 million, or","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1674930/000119312526199061/0001193125-26-199061-index.htm","confidence":0.98,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2026"},{"label":"Revenue","value":"71.1 million"},{"label":"Net income","value":"-24.8 million"},{"label":"EPS","value":"-0.80"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}